Raw Ventures — 2024 Investments
1 investments dated 2024 · listed companies and verified rows first · show all
iFASTifastdiagnostics.cominNov 2024✓ verified
iFAST Diagnostics develops rapid antimicrobial susceptibility testing (AST) technology that delivers susceptibility test results in under 3 hours, significantly faster than the standard 40-hour process.
BiotechHealthtechMedical DevicesWhiteley, GB
Toby King(CEO)in
Co-investorsMeridian Health VenturesCambridge Capital GroupInnovate UKFuture Planet CapitalUK Innovation & Science Seed Fund
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.